CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM
Unresolved Excipient
Suggest One
No specific molecular structure known for this excipient.
- CAS
- 9004324
- UNII
- K679OBS311
- SYNONYMS
-
- ZINC ID(s)
-
- Availability
- Present in 0 ZINC catalogs
Known Active Genes
There has not been any activity reported at 10μM or less for this excipient (per ChEBML)
Clinical Trials
This compound has not been in (or located in) any clinical trials (per clinicaltrials.gov).
(Browse) Purchasable Analogs in ZINC
Analogs cannot be located as there is no structure provided for this compound. Try a
search by name.
Dosages
| Route | Formulation | Per Unit Dose |
|---|---|---|
| Buccal | Film | 17.64MG |
| Dental | Gel | 0.4% |
| Dental | Paste | 174MG |
| Im - Iv | Injection | |
| Intra-Articular | Injectable | 0.75% |
| Intra-Articular | Injection | 0.76% |
| Intra-Articular | Injection, Sustained Action | |
| Intrabursal | Injection | 0.76% |
| Intradermal | Injection | |
| Intradermal | Injection, Sustained Action | |
| Intraduodenal | Gel | 2.92% |
| Intralesional | Injection | |
| Intralesional | Injection, Sustained Action | |
| Intramuscular | Injectable | 0.75% |
| Intramuscular | Injection | 3% |
| Intramuscular | Injection | 7.5MG |
| Intramuscular | Injection, Microspheres | 1% |
| Intramuscular | Injection, Sustained Action | |
| Intramuscular | Powder, For Injection Solution, Lyophilized | 3% |
| Intramuscular | Powder, For Injection Suspension | 0.7% |
| Intrasynovial | Injection | 0.1% |
| Intrasynovial | Injection, Sustained Action | |
| Intratracheal | Suspension | |
| Intravitreal | Suspension, Injection | 0.5% |
| Iv(infusion) | Gel | 2.92% |
| Nasal | Spray, Metered | 0.15% |
| Ophthalmic | Solution | 0.5% |
| Ophthalmic | Solution, Drops | 0.5% |
| Oral | Capsule | 160MG |
| Oral | Capsule, Delayed Action, Coated, Hard Gelatin | 4MG |
| Oral | Capsule, Enteric Coated Pellets | 4.2MG |
| Oral | Capsule, Hard Gelatin | |
| Oral | Capsule, Sustained Action | 0.47MG |
| Oral | Drops | 0.51% |
| Oral | Granule | 25.7MG |
| Oral | Granule, For Suspension | |
| Oral | Powder, For Oral Solution | 2.6MG |
| Oral | Powder, For Oral Solution | 1.19%W/W |
| Oral | Powder, For Solution | 0.26% |
| Oral | Powder, For Suspension | 1% |
| Oral | Suspension | 40% |
| Oral | Suspension, Drops | 0.1% |
| Oral | Suspension, Syrup, Sustained Action | 0.02% |
| Oral | Tablet | 48MG |
| Oral | Tablet (immed./comp. Release), Uncoated, Chewable | 24.75MG |
| Oral | Tablet, Coated | 3.2MG |
| Oral | Tablet, Delayed Action | 50MG |
| Oral | Tablet, Extended Release | 119.82MG |
| Oral | Tablet, Film Coated | 50MG |
| Oral | Tablet, Film Coated, Extended Release | 50.02MG |
| Oral | Tablet, Sustained Action | 155MG |
| Soft Tissue | Injection | 0.5% |
| Subcutaneous | Implant | 16MG |
| Subcutaneous | Injection | |
| Topical | Film, Controlled Release | |
| Topical | Jelly | |
| Topical | Lotion | |
| Topical | Paste | |
| Topical | Patch | |
| Topical | Patch, Controlled Release | |
| Topical | Solution | 0.33%W/V |
| Vaginal | Emulsion, Aerosol Foam | 0.2% |